NASDAQ:XAIR Beyond Air (XAIR) Stock Price, News & Analysis $0.59 0.00 (-0.20%) (As of 09:15 AM ET) Add Compare Share Share Today's Range$0.59▼$0.5950-Day Range$0.54▼$1.3952-Week Range$0.54▼$4.24Volume34,596 shsAverage Volume534,640 shsMarket Capitalization$27.03 millionP/E RatioN/ADividend YieldN/APrice Target$5.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Beyond Air alerts: Email Address Beyond Air MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside876.6% Upside$5.75 Price TargetShort InterestBearish7.34% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.03) to ($0.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.32 out of 5 starsMedical Sector263rd out of 879 stocksSurgical & Medical Instruments Industry34th out of 95 stocks 3.3 Analyst's Opinion Consensus RatingBeyond Air has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageBeyond Air has only been the subject of 3 research reports in the past 90 days.Read more about Beyond Air's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted7.34% of the outstanding shares of Beyond Air have been sold short.Short Interest Ratio / Days to CoverBeyond Air has a short interest ratio ("days to cover") of 5.9.Change versus previous monthShort interest in Beyond Air has recently decreased by 3.99%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldBeyond Air does not currently pay a dividend.Dividend GrowthBeyond Air does not have a long track record of dividend growth. Previous Next 3.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreBeyond Air has received a 41.63% net impact score from Upright. Beyond Air seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Creating knowledge". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Medical ventilators", "Clinical research services for the respiratory system", and "Preclinical research services for physical health" products. See details.Environmental SustainabilityThe Environmental Impact score for Beyond Air is -0.91. Previous Next 0.6 News and Social Media Coverage Search Interest3 people have searched for XAIR on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Beyond Air to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Beyond Air insiders have not sold or bought any company stock.Percentage Held by Insiders19.00% of the stock of Beyond Air is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 31.50% of the stock of Beyond Air is held by institutions.Read more about Beyond Air's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Beyond Air are expected to grow in the coming year, from ($1.03) to ($0.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Beyond Air is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Beyond Air is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBeyond Air has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Beyond Air's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Insiders ExposedHow did they achieve a perfect track record? If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...Just click this link and follow along About Beyond Air Stock (NASDAQ:XAIR)Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.Read More XAIR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XAIR Stock News HeadlinesJune 25, 2024 | investorplace.comWhy Is Beyond Air (XAIR) Stock Down 22% Today?June 24, 2024 | globenewswire.comBeyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateJuly 8, 2024 | Colonial Metals (Ad)Silver Expected for Extreme Price ActionOur newest Silver Investing Guide reveals how savvy investors are capitalizing on silver's continued rise – PLUS a little-known loophole that allows investors to move a portion of their savings into silver, tax-free and penalty-free.June 13, 2024 | globenewswire.comBeyond Air® Appoints David Webster as Chief Commercial OfficerJune 3, 2024 | globenewswire.comBeyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)May 23, 2024 | globenewswire.comBeyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and WebcastMay 13, 2024 | skift.comAkasa Air’s Plan to Expand Beyond IndiaMay 1, 2024 | finance.yahoo.comBeyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual MeetingJuly 8, 2024 | Colonial Metals (Ad)Silver Expected for Extreme Price ActionOur newest Silver Investing Guide reveals how savvy investors are capitalizing on silver's continued rise – PLUS a little-known loophole that allows investors to move a portion of their savings into silver, tax-free and penalty-free.April 27, 2024 | yahoo.comBeyond Paradise, series 2 finale, review: forget Doctor Who, Kris – this show is perfect for youApril 27, 2024 | yahoo.comBBC reveals future of Beyond Paradise after surprise twistApril 10, 2024 | msn.comBeyond the Horizon Air and Space Show ends with record number of spectatorsMarch 20, 2024 | markets.businessinsider.comBeyond Air Prices Direct Offering Of $16 Mln Of Shares, WarrantsMarch 20, 2024 | globenewswire.comBeyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and WarrantsMarch 16, 2024 | yahoo.comBeyond Paradise star teases a different side to her character in season 2February 23, 2024 | realmoney.thestreet.comWill Renewed Nvidia Excitement Lift the Entire Market?February 20, 2024 | yahoo.comBed Bath & Beyond has a new CEO, air quality’s rising impact on real estate and moreFebruary 13, 2024 | investing.comBeyond Air (XAIR) Earnings Dates & ReportsSee More Headlines Receive XAIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/24/2024Today7/08/2024Next Earnings (Estimated)8/08/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:XAIR CUSIPN/A CIK1641631 Webwww.beyondair.net Phone(516) 665-8200FaxN/AEmployees98Year FoundedN/APrice Target and Rating Average Stock Price Target$5.75 High Stock Price Target$8.00 Low Stock Price Target$3.50 Potential Upside/Downside+874.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.82) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-60,240,000.00 Net Margins-5,197.76% Pretax Margin-5,547.46% Return on Equity-203.12% Return on Assets-100.44% Debt Debt-to-Equity Ratio0.54 Current Ratio3.80 Quick Ratio3.61 Sales & Book Value Annual Sales$1.16 million Price / Sales23.35 Cash FlowN/A Price / Cash FlowN/A Book Value$0.75 per share Price / Book0.79Miscellaneous Outstanding Shares45,900,000Free Float37,180,000Market Cap$27.08 million OptionableOptionable Beta-0.10 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Steven Adam Lisi (Age 53)CEO & Chairman of the Board Comp: $650kMr. Amir Avniel (Age 50)Co-Founder, President, Chief Business Officer & Director Comp: $400kMr. Michael A. Gaul (Age 69)Chief Operating Officer Comp: $350kMr. Douglas Quinton Larson (Age 53)CFO, Principal Financial Officer & Principal Accounting Officer Comp: $274.95kEdward BargerHead of Investor RelationsMs. Kori-Ann TaylorHead of MarketingDr. Andrew R. Colin M.D.Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory BoardDr. Jeff Myers M.D. (Age 59)Ph.D., Chief Medical Officer Mr. Adam NewmanCorporate SecretaryMore ExecutivesKey CompetitorsTELA BioNASDAQ:TELABlueRiver AcquisitionNYSE:BLUABrainsWayNASDAQ:BWAYHealth Sciences Acquisitions Co. 2NASDAQ:HSAQSensus HealthcareNASDAQ:SRTSView All CompetitorsInsiders & InstitutionsGendell Jeffrey LBought 340,774 shares on 5/15/2024Ownership: 4.054%Vanguard Group Inc.Bought 66,224 shares on 5/10/2024Ownership: 3.883%Rosalind Advisors Inc.Bought 903,614 shares on 4/25/2024Ownership: 2.507%Wealth Effects LLCSold 35,000 shares on 4/23/2024Ownership: 1.135%Amir AvnielSold 11,267 sharesTotal: $23,210.02 ($2.06/share)View All Insider TransactionsView All Institutional Transactions XAIR Stock Analysis - Frequently Asked Questions How have XAIR shares performed this year? Beyond Air's stock was trading at $1.96 at the beginning of 2024. Since then, XAIR shares have decreased by 70.0% and is now trading at $0.5888. View the best growth stocks for 2024 here. How were Beyond Air's earnings last quarter? Beyond Air, Inc. (NASDAQ:XAIR) issued its earnings results on Monday, June, 24th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.47) by $0.11. The company earned $0.47 million during the quarter, compared to analysts' expectations of $0.71 million. Beyond Air had a negative trailing twelve-month return on equity of 203.12% and a negative net margin of 5,197.76%. How do I buy shares of Beyond Air? Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Beyond Air own? Based on aggregate information from My MarketBeat watchlists, some other companies that Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH) and General Motors (GM). This page (NASDAQ:XAIR) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happ...Porter & Company | SponsoredTrump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house...Wealthpin Pro | SponsoredNew Government Policy to Wipe Out Seniors WealthDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beyond Air, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beyond Air With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
